Microbot Medical Inc. (MBOT) — 分析师展望 / 分析师共识目标价为. 基于 3 位分析师评级, 共识为 看涨 — 2 买入, 1 持有.
分析师共识目标价为 $5.50, 上涨空间为 126.3% 相对于当前价格 $2.43.
分析师预估 每股收益(EPS)为 $-0.71 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $0.01 vs 预期 $-0.71 (超预期 +101.6%). 2025: 实际 $-0.29 vs 预期 $-0.30 (超预期 +3.3%). 分析师准确度: 0%.
MBOT 股票 — 12个月价格预测
$5.50
▲ +126.34% 上涨空间
平均目标价
Based on 3 Wall Street analysts offering 12-month price targets for Microbot Medical Inc., the price target is $5.50.
平均目标价相对最新价格 $2.43 变动 +126.34%。
MBOT 分析师评级
Buy
基于过去3个月内 3 位分析师对 Microbot Medical Inc. 的评级
EPS 预测 — MBOT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.01
vs Est –$0.71
▲ 6,220.7% off
2025
Actual –$0.29
vs Est –$0.30
▲ 3.4% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect losses to continue near-term.
营收预测 — MBOT
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
